Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CloudMD Software & Services Inc V.DOC

Alternate Symbol(s):  DOCRF

CloudMD Software & Services Inc. is a healthcare service provider. The Company operates through two divisions: Health and Wellness Services (HWS) and Health and Productivity Solutions (HPS). HWS operates through two models: subscription-based pricing using a price per member per month with an average contractual term of three years; and a per-case billing model at an agreed-upon rate for services that are used in disability management, occupational health, and other employer services. HPS division offers health and productivity tools intended to create a better experience for those needing healthcare. The Company’s workplace health and wellbeing solution, Kii, supports members and their families with a personalized and connected healthcare experience across mental, physical and occupational health. Kii delivers superior clinical health outcomes, consistent high engagement, and measurable ROI for payers such as employers, educational institutions, associations, governments and insurers.


TSXV:DOC - Post by User

Comment by Tuataraon Dec 02, 2021 1:18pm
381 Views
Post# 34190956

RE:$ 3.00 Price Target

RE:$ 3.00 Price Target

Interesting. They're lazy because their numbers doing tie to company statements ie $185MM run rate and an organic projection of min 10%.

Q3 Rev was $39MM so why would Cannacord model $37MM for Q4?

Doc via continued QoQ organic growth should incrementally increase to mid $200's by end 2022 IMO

<< Previous
Bullboard Posts
Next >>